ANAVEX LIFE SCIENCES CORP.

AVXL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 34 employees
246
SEC Filings
$2.7
Close 2026-07-30
34
Employees

Business Summary

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company developing precision medicine therapeutics for central nervous system diseases including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia, and other neurodegenerative and neurodevelopmental disorders. Its lead compound, ANAVEX 2-73 (blarcamesine), targets sigma-1 and muscarinic receptors and is in multiple clinical trials. A second compound, ANAVEX 3-71, is in one clinical trial. The company uses genomic biomarker analysis and AI-driven machine learning to support precision medicine approaches.

Latest Stock Quote

AVXL 2026-07-30 $2.7 O:$2.51 H:$2.71 L:$2.51 Vol:1.2M VWAP:$2.6276
origin leaf: null

Next Earnings

expected 2026-10-19

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-11-252025-09-300001731122-25-001596EDGAR76K words
2024-12-232024-09-300001731122-24-002041EDGAR—
2023-11-272023-09-300001731122-23-002197EDGAR—
2022-11-282022-09-300001731122-22-002062EDGAR—
2021-11-242021-09-300001731122-21-002062EDGAR—
2020-12-282020-09-300001731122-20-001338EDGAR—
2019-12-162019-09-300001731122-19-000784EDGAR—
2018-12-122018-09-300001615774-18-014328EDGAR—
2017-12-112017-09-300001615774-17-007272EDGAR—
2016-12-142016-09-300001615774-16-008914EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-092025-12-310001731122-26-000200EDGAR21K words
2025-08-122025-06-300001731122-25-001105EDGAR—
2025-05-132025-03-310001731122-25-000724EDGAR—
2025-02-122024-12-310001731122-25-000205EDGAR—
2024-08-062024-06-300001731122-24-001207EDGAR—
2024-05-092024-03-310001731122-24-000760EDGAR—
2024-02-072023-12-310001731122-24-000206EDGAR—
2023-08-082023-06-300001731122-23-001412EDGAR—
2023-05-092023-03-310001731122-23-000845EDGAR—
2023-02-072022-12-310001731122-23-000152EDGAR—
2022-08-092022-06-300001731122-22-001301EDGAR—
2022-05-102022-03-310001731122-22-000851EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-110001731122-26-001042EDGAR—
2026-08-030001731122-26-001000EDGAR—
2026-07-300001731122-26-000988EDGAR—
2026-07-200001731122-26-000957EDGAR—
2026-03-250001731122-26-000482EDGAR1K words
2026-02-250001731122-26-000305EDGAR—
2026-02-090001731122-26-000193EDGAR—
2025-11-250001731122-25-001591EDGAR—
2025-11-140001731122-25-001536EDGAR—
2025-07-280001731122-25-001033EDGAR—

246 total filings indexed. 214 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC ARGX — ARGENX SE ABPO — Abpro Holdings, Inc.

Tags

alzheimer's-disease parkinson's-disease rett-syndrome fragile-x-syndrome schizophrenia neurodegenerative-diseases neurodevelopmental-diseases rare-diseases mixed-model-for-repeated-measures-(mmrm) positron-emission-tomography-(pet)-imaging machine-learning/ai-genomic-analysis

Company Identity

CIK0001314052
TickerAVXL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.anavex.com
Listed2006-08-02

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 894393df5e1739fe424e11b33ae899b8279b56f721d07c699e999be8b67ace97
parent: eb7d6013ce35883355a054119244d8d5150b8b9cb912730120bc9cd854bd781c
content hash: 76dd28e48bc233ca94ca4ced712d0a6c22639ebf8637cfcef76761f42e979151
signed: 2026-08-12T19:00:58.638Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AVXL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AVXL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AVXL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.